MindSave Official Website › Notebook › Twelve Weeks Is The Number To Plan A Cognition Supplement Around
Twelve Weeks Is The Number To Plan A Cognition Supplement Around
A label can withhold how much of something is in a capsule. A published trial cannot withhold how long it ran, and that single number decides more about whether a purchase was a fair test than anything printed on a bottle.
- Twelve weeks. Every bacopa monnieri trial in the published systematic review ran that long, and the meta-analysis would not admit a shorter one.
- Sixteen weeks. The largest placebo-controlled huperzine A trial ran at least that long.
- Sixty days. The typical money-back window on this shelf, which is a little under nine weeks.
- The gap is the point. Buy a pack that covers the test you intend to run, and know which side of the window you are deciding on.
Why duration is the number nobody checks
Ask most people what they look at on a supplement label and they will say the ingredients, or the price. Almost nobody says the duration of the research behind it, which is odd, because duration is the one figure that is always published, always free, and always in the abstract.
It is also the figure that decides whether your own test was fair. A capsule with a twelve-week evidence base, judged at day ten, has not been tested. It has been interrupted.
What the published durations actually are
Here are the four numbers that bear on a label like this one, and where each comes from.
| Number | Source | What it is |
|---|---|---|
| 12 weeks | the systematic review of bacopa monnieri | Every included trial ran twelve weeks. The meta-analysis set twelve weeks as an inclusion criterion, which tells you what the field considers a minimum. |
| 16 weeks | the largest huperzine A trial | At 200 or 400 micrograms twice a day, in people with a dementia diagnosis rather than healthy adults. Its primary analysis found no cognitive effect at the lower dose. |
| 12 weeks | the phosphatidylserine trial behind the FDA qualified health claim | One hundred milligrams three times a day. The trial of the soy form sold today also ran twelve weeks and found no difference from placebo. |
| 5 days | the tyrosine combat-course trial | The exception that proves the rule. Tyrosine's positive findings cluster in short, acutely stressful conditions rather than over months. |
Durations are what each paper reports. None of them is a claim about any finished product.
Three of the four run twelve weeks or more. The fourth is five days, and it is five days because it was testing something else entirely: performance under acute stress, not everyday recall.
Why twelve weeks, and not four
Twelve weeks is not a convention borrowed from another category. It is what the bacopa literature decided a trial has to be before it counts at all. The 2014 meta-analysis pooled nine studies and 437 subjects, and it would only admit trials of chronic dosing lasting twelve weeks or more. A rule about what qualifies as a trial is also a statement about how long the thing being trialled takes.
What that pooled analysis found is worth giving in its own units, because the units are modest: about 17.9 milliseconds on the Trail B test and about 10.6 milliseconds on choice reaction time. Its own caveat is that only a large, well-designed head-to-head trial will settle the question.
One of the individual trials shows how carefully that twelve weeks is measured. It gave 300 mg a day for twelve weeks to 54 participants aged 65 and over with no clinical signs of dementia, and it put a six-week placebo run-in in front of the dosing period. Eighteen weeks of study to measure twelve weeks of capsule. Delayed word recall and the Stroop test improved; the divided attention task and the digit task did not.
The run-in is the part a home test can never copy. Six weeks of placebo before the real thing starts is how a trial strips out the improvement that comes from being watched, tested twice and turning up. Nobody at a kitchen table has one, which is a good reason to distrust a week-one impression.
That trial is also the source of the least glamorous number in this literature. Adverse events were few and primarily stomach upset: nine of them on bacopa against ten on placebo.
The two clocks on a cognition label
Not everything on a cognition panel is measured in weeks, and the ingredients that are not were not failing the twelve-week rule. They were asked a different question.
Tyrosine is the clearest case on this panel. The combat-course trial gave 2 g a day in a protein-rich drink across five days of a demanding military training course to 21 cadets, assessed before the course and again on day six. The tyrosine group did better on a memory task and a tracking task and their systolic blood pressure fell; mood did not move. Five days, because the exposure being tested was the course rather than the amino acid.
The counterweight is shorter still: a single dose of 150 mg per kilogram of body weight, ninety minutes before testing, in 24 healthy adults aged 61 to 72. Across the group it changed neither reactive nor proactive inhibition, and with increasing age it was increasingly detrimental to proactive response slowing. The young-and-stressed literature does not simply extend to older adults.
The US military’s graded assessment read ten randomised controlled trials and four controlled clinical trials, made a weak recommendation in favour for cognitive stress and none at all for physical performance, and wrote its ceiling into its own conclusion: the available evidence is insufficient to make confident recommendations.
| The clock | Ingredient | What the study actually did |
|---|---|---|
| Weeks of steady use | Bacopa monnieri | Six trials, every one of them twelve weeks, at 300 to 450 mg a day of a standardised extract. Judge it at twelve weeks or do not judge it. |
| Days inside a stressor | L-Tyrosine | Five daily doses of 2 g during a military training course (Deijen 1999). The positive findings cluster in short, acutely demanding conditions. |
| Ninety minutes before a task | L-Tyrosine, again | A single 150 mg per kg dose before testing in adults aged 61 to 72 (Bloemendaal 2018), which moved nothing across the group. |
| Sixteen weeks, and it still missed | Huperzine A | 200 or 400 micrograms twice a day for at least sixteen weeks (Rafii 2011), in people with a dementia diagnosis rather than healthy adults. The primary analysis found no cognitive effect at the lower dose. |
Each row describes a study design as the cited paper reports it. None of it describes a finished product, and no quantity in this table is a suggestion about what to take.
So the first question to ask about an ingredient is not whether it works. It is which clock it was tested on. Something measured ninety minutes before a task has nothing to say about week six, and something measured across twelve weeks has nothing to say about this afternoon.
What that means for a sixty-day guarantee
Sixty days is a little under nine weeks. Twelve weeks is about eighty-four days. So a sixty-day window covers roughly two thirds of the shortest trial in the strongest ingredient's evidence base.
That is not a scandal and it is not unusual. It is simply a fact worth knowing before you choose a pack, because it turns a vague decision into a concrete one: are you buying enough capsules to run the test, and are you deciding on the refund before or after the test finishes?
On this website the two dates are set out on the guarantee page, where the seller’s own advice to use the product consistently for three to six months is quoted beside its own sixty-day window. Both sentences belong to the seller and both are printed unedited.
How to run a fair test at home
- Write down the date of the first capsule. Everything else is counted from it.
- Change nothing else in the same fortnight. A new capsule and a new bedtime started together cannot be told apart afterwards.
- Do not judge it in week one. Nothing on a label like this has a week-one trial behind it, and week-one disappointment is the commonest complaint on every review roster in this category.
- Write down what you notice at week three or four rather than trying to remember it later.
- Decide on the refund by the window, and on the product by the research. Those are two different dates and they should be two different decisions.
That is the whole method. It costs nothing, it needs no equipment, and it is the difference between finding something out and simply spending money. The timeline page carries the same four numbers for this particular product, and the ingredients page carries what the trials used for each of its eight names.
What duration cannot tell you
Duration is the most checkable figure in this category and it is still only one figure. It says how long a study ran. It says nothing about whether the study found anything, and three of the four durations in the first table sit underneath results that are either narrow or null.
It is worth ending on the ceiling the field publishes about itself. The National Institute on Aging puts it in a single sentence: at this time, no vitamin or supplement is recommended for preventing Alzheimer’s or other forms of cognitive decline. That is not a verdict on any particular bottle. It is the state of the field, and it is the sentence worth holding in mind while running the twelve-week test described above.
What duration does do is make your own test fair, and it does that without a single milligram. The sales page for this product names eight ingredients and puts no amount beside any of them, so comparing one capsule with a trial dose is not available to a buyer here. Comparing your own run with a trial length is, and it never depends on a number somebody chose not to print.
The label page sets out what this product does and does not publish, and why two published documents describe it differently.
A note on what this is. MindSave is a dietary supplement, not a medicine. Nothing in this post describes it as a treatment for dementia, Alzheimer’s disease or mild cognitive impairment, and no supplement is currently recommended for preventing cognitive decline. Memory or thinking that is changing in a way that worries you is a reason to be assessed by a clinician, not a reason to start a capsule.
Sources cited in this article
- Pase MP, Kean J, Sarris J, Neale C, Scholey AB, Stough C. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012;18(7):647-52. PMID 22747190. https://pubmed.ncbi.nlm.nih.gov/22747190/
- Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528-35. PMID 24252493. https://pubmed.ncbi.nlm.nih.gov/24252493/
- Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707-13. PMID 18611150. https://pubmed.ncbi.nlm.nih.gov/18611150/
- Attipoe S, Zeno SA, Lee C, Crawford C, Khorsan R, Walter AR, Deuster PA. Tyrosine for Mitigating Stress and Enhancing Performance in Healthy Adult Humans, a Rapid Evidence Assessment of the Literature. Mil Med. 2015;180(7):754-65. PMID 26126245. https://pubmed.ncbi.nlm.nih.gov/26126245/
- Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999;48(2):203-9. PMID 10230711. https://pubmed.ncbi.nlm.nih.gov/10230711/
- Bloemendaal M, Frobose MI, Wegman J, Zandbelt BB, van de Rest O, Cools R, Aarts E. Neuro-Cognitive Effects of Acute Tyrosine Administration on Reactive and Proactive Response Inhibition in Healthy Older Adults. eNeuro. 2018;5(2):ENEURO.0035-17.2018. PMID 30094335. https://pubmed.ncbi.nlm.nih.gov/30094335/
- Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76(16):1389-94. PMID 21502597. https://pubmed.ncbi.nlm.nih.gov/21502597/
- Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 1991;41(5):644-9. PMID 2027477. https://pubmed.ncbi.nlm.nih.gov/2027477/
- Jorissen BL, Brouns F, Van Boxtel MP, Ponds RW, Verhey FR, Jolles J, Riedel WJ. The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci. 2001;4(2):121-34. PMID 11842880. https://pubmed.ncbi.nlm.nih.gov/11842880/
- National Institute on Aging, National Institutes of Health. Cognitive Health and Older Adults. https://www.nia.nih.gov/health/brain-health/cognitive-health-and-older-adults
MindSave, on the official website
One capsule a day, thirty to a bottle, eight ingredients named on the label. Sixty days to change your mind, and the bottles go back even if they are empty.
Order MindSave